openPR Logo
Press release

Biochips Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Roche Ltd, Fluidigm Corporation, Illumina, HORIBA, PerkinElmer, QIAGEN N.V.

04-12-2022 05:49 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Biochips Market

Biochips Market

The biochip is used to simultaneously analyze a panel of related tests in a single sample, producing a patient profile. The patient profile can be used in disease screening, diagnosis, monitoring disease progression or monitoring treatment.

DelveInsight's 'Biochips Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Biochips and the historical and forecasted Biochips market trends, globally, which comprises of North America, Europe, APAC, and RoW.

To Know more about Biochips Market report: https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Biochips Companies are:
• bioMrieux S.A.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation
• Illumina, Inc.
• HORIBA, Ltd.
• PerkinElmer, Inc.
• QIAGEN N.V.
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• And Many Others

For further information on the Biochips companies and their pipeline, reach out @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some Facts of Biochips Market Report are:

• As per National Cancer Institute, by 2040, it is projected that the number of new cancer cases will upsurge by 29.5 million and the number of cancer-related deaths to 16.4 million per year.
• The increasing prevalence of chronic diseases is poised to help the market grow. As per world health organization (WHO), an estimated 17.9 million people died from Cardiovascular diseases (CVDs) in 2019, which represented 32% of all global deaths.
• In 2019, as per American Heart Association, 2019 around 121.5 million U.S. adults have some form of cardiovascular disease.
• In Europe, the market is growing owing to factors such as presence of prominent players that have adopted substantial strategies such as product launch and acquisitions etc. and rising prevalence of cancer diseases as biochips transform the way in which medical field diagnoses cancer.
• In 2020, as per American cancer society, Europe accounts for 22.8% of the total cancer cases and 19.6% of the cancer deaths. Asia Pacific is supplemented by factors such as huge number of the patient pool which requires early detection of diseases and presence of major players in the market is propelling the growth.

Request for Sample Report: https://www.delveinsight.com/sample-request/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Biochips Market Drivers:
Increase in prevalence of cancer, immunological disorders, and viral infections majorly drives the growth of the global biochips market. Other factors that boost the market growth include rise in geriatric population, increase in number of biochip applications, and high adoption of personalized medications. However, factors such as high cost of biochip and lack of knowledge about it majorly in emerging nations hamper the market growth.

For further information on the Biochips companies and their pipeline, reach out @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Biochips Market Report

• The report covers the descriptive overview of Biochips, explaining its applications, advantages, and limitations, etc.
• Additionally, detailed profiles of the Key Companies operating in the market is provided, along with the market share of the Key 3-5 players.
• A detailed review of Biochips market; historical and forecasted market size is included in the report, covering global outreach.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Biochips market.

Find a sample copy of the Biochips Market report: https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Biochips Market Report Introduction
2. Biochips Market Executive summary
3. Regulatory and Patent Analysis
4. Biochips Market Key factors analysis
5. Biochips Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Biochips Market
7. Biochips Market layout
8. Biochips Global Company Share Analysis - Key 3-5 Companies
9. Biochips Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Request for TOC @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biochips Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Roche Ltd, Fluidigm Corporation, Illumina, HORIBA, PerkinElmer, QIAGEN N.V. here

News-ID: 2600479 • Views:

More Releases from DelveInsight Business Research

Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market. As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates. The Vitiligo Pipeline report offers extensive commercial and clinical
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Myelodysplastic Syndrome Pipeline Report • DelveInsight's Myelodysplastic Syndrome
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape. The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market. The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment

All 5 Releases


More Releases for Biochips

Impact of Personalized Medicine On Biochips Market: Pivotal Factor Influencing B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biochips Market Size Growth Forecast: What to Expect by 2025? In recent years, the size of the biochips market has seen significant expansion. It is forecasted to rise from $12.62 billion in 2024 to $14.72 billion in 2025, with a compound annual growth rate (CAGR) of 16.6%. The surge
Impact of Personalized Medicine On Biochips Market: A Key Driver Powering Biochi …
The Biochips Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Biochips Market Size and Its Estimated Growth Rate? The biochips market has seen rapid growth in recent years. It is expected to grow from $12.62 billion in 2024 to $14.72 billion in
Primary Catalyst Driving Biochips Market Evolution in 2025: Impact of Personaliz …
Which drivers are expected to have the greatest impact on the over the biochips market's growth? The biochips market is expected to thrive due to the rising acceptance of personalized medicines. Tailoring medical treatment according to an individual's specific characteristics like genetics or lifestyle defines personalized medicine. It's been witnessing an increase in demand on account of its ability to offer more efficient treatments, advancements in genomics, the rise in disease
Biochips Market: Crucial Role of Biochips in Drug Discovery and Development
The vendor landscape of the global biochips market is extremely fragmented, speckled with a number of small, medium, and large enterprises. Considering that it is not a monopolistic scenario, the entry of new players is not restricted, giving vendors immense scope. In view of this, Transparency Market Research finds that despite being the leading players in the biochips market, Affymetrix Inc., Agilent Technologies Inc., and Illumina Inc. together accounted for
Biochips Market Report
According to the new market research report, “Biochips Market, by Types (Protein Chips, DNA Chips, Lab-on-a-chip), Fabrication Technologies (Microarrays, Microfluidics), Applications (Drug Discoveries, Gene Expression, Genomics, In-vitro Diagnostics, Proteomics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022”, published by Scalar Market Research, the global biochips market is expected to grow at a healthy rate during the forecast period. The global biochips market report offers in-depth analysis of the
Biochips Market Rises due to Rising Investments in Development of Biochips Techn …
Biochips are a collection of microarrays or micro-test sites fixed on a solid substrate to perform multiple tests at the same time for achieving enhanced speed and throughput. They are small, wafer-like components that are made from substrates such as soda glass, fused quartz, silicon, and plastic. Biochips are effectively a miniature laboratory that functions to perform several biochemical reactions simultaneously. INFORMATION OF BIOCHIPS MARKET WORLDWIDE: http://www.transparencymarketresearch.com/biochips-market.html The positive growth rate in the